U.S. Assisted Reproductive Technology Market Size, Share & Trends Analysis Report By Type (In-Vitro Fertilization (IVF), Artificial Insemination), By End-use (Fertility Clinics & Other Facilities, Hospitals & Other Settings), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Type
                        1.2.2. End-use
                        1.2.3. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in the U.S.
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Type outlook
                        2.2.2. End-use outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Assisted Reproductive Technology Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Constant rise in infertility rates
                            3.2.1.2. Growing awareness and social acceptance of ART
                            3.2.1.3. Increasing number of single women and same-sex couples
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Changing government regulations
                    3.3. U.S. Assisted Reproductive Technology Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s Five Forces
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
Chapter 4. U.S. Assisted Reproductive Technology Market: Type Estimates & Trend Analysis
                    4.1. U.S. Assisted Reproductive Technology Market: Type Dashboard
                    4.2. U.S. Assisted Reproductive Technology Market: Type Analysis
                    4.3. U.S. Assisted Reproductive Technology Market: Size & Forecasts and Trend Analyses, 2018 to 2030
                        4.3.1. In-Vitro Fertilization (IVF)
                            4.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.3.1.2. Fresh Donor
                                4.3.1.2.1. Fresh Donor Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                            4.3.1.3. Frozen Donor
                                4.3.1.3.1. Frozen Donor Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                            4.3.1.4. Fresh Non-Donor
                                4.3.1.4.1. Fresh Non-Donor Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                            4.3.1.5. Frozen Non-Donor
                                4.3.1.5.1. Frozen Non-Donor Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                        4.3.2. Artificial Insemination
                            4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.3.2.2. Intrauterine Insemination
                                4.3.2.2.1. Intrauterine Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                            4.3.2.3. Intracervical Insemination
                                4.3.2.3.1. Intracervical Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                            4.3.2.4. Intravaginal Insemination
                                4.3.2.4.1. Intravaginal Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                            4.3.2.5. Intratubal Insemination
                                4.3.2.5.1. Intratubal Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. U.S. Assisted Reproductive Technology Market: End-use Estimates & Trend Analysis
                    5.1. U.S. Assisted Reproductive Technology Market: End-use Dashboard
                    5.2. U.S. Assisted Reproductive Technology Market: End-use Analysis
                    5.3. U.S. Assisted Reproductive Technology Market: Size & Forecasts and Trend Analyses, 2018 to 2030
                        5.3.1. Fertility Clinics & Other Facilities
                            5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.3.2. Hospitals & Other Settings
                            5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
                    6.1. Recent Developments & Impact Analysis, By Key Market Participants
                    6.2. Company/Competition Categorization
                    6.3. Vendor Landscape
                        6.3.1. List of key distributors and channel partners
                        6.3.2. Key customers
                        6.3.3. Key company market share analysis, 2023
                        6.3.4. Cosmos Biomedical Ltd.
                            6.3.4.1. Company overview
                            6.3.4.2. Financial performance
                            6.3.4.3. Product benchmarking
                            6.3.4.4. Strategic initiatives
                        6.3.5. Microm U.K. Ltd.
                            6.3.5.1. Company overview
                            6.3.5.2. Financial performance
                            6.3.5.3. Product benchmarking
                            6.3.5.4. Strategic initiatives
                        6.3.6. CooperSurgical, Inc.
                            6.3.6.1. Company overview
                            6.3.6.2. Financial performance
                            6.3.6.3. Product benchmarking
                            6.3.6.4. Strategic initiatives
                        6.3.7. FUJIFILM Irvine Scientific
                            6.3.7.1. Company overview
                            6.3.7.2. Financial performance
                            6.3.7.3. Product benchmarking
                            6.3.7.4. Strategic initiatives
                        6.3.8. Cryolab Ltd.
                            6.3.8.1. Company overview
                            6.3.8.2. Financial performance
                            6.3.8.3. Product benchmarking
                            6.3.8.4. Strategic initiatives
                        6.3.9. Vitrolife AB
                            6.3.9.1. Company overview
                            6.3.9.2. Financial performance
                            6.3.9.3. Product benchmarking
                            6.3.9.4. Strategic initiatives
                        6.3.10. European Sperm Bank
                            6.3.10.1. Company overview
                            6.3.10.2. Financial performance
                            6.3.10.3. Product benchmarking
                            6.3.10.4. Strategic initiatives
                        6.3.11. Bloom IVF Centre
                            6.3.11.1. Company overview
                            6.3.11.2. Financial performance
                            6.3.11.3. Product benchmarking
                            6.3.11.4. Strategic initiatives
                        6.3.12. Merck KGaA
                            6.3.12.1. Company overview
                            6.3.12.2. Financial performance
                            6.3.12.3. Product benchmarking
                            6.3.12.4. Strategic initiatives
                        6.3.13. Ferring B.V.
                            6.3.13.1. Company overview
                            6.3.13.2. Financial performance
                            6.3.13.3. Product benchmarking
                            6.3.13.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. assisted reproductive technology market, by type, 2018 - 2030 (USD Million)
Table 3 U.S. assisted reproductive technology market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Assisted Reproductive Technology market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Type and end-use segment snapshot
Fig. 10 Competitive landscape snapshot
Fig. 11 Market dynamics
Fig. 12 Porter’s Five Forces analysis
Fig. 13 PESTLE analysis
Fig. 14 Assisted Reproductive Technology market: Type outlook and key takeaways
Fig. 15 Assisted Reproductive Technology market: Type movement analysis
Fig. 16 In-Vitro Fertilization (IVF) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Fresh Donor market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Frozen Donor market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Fresh Non-Donor market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Frozen Non-Donor market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Artificial Insemination market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Intrauterine Insemination market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Intracervical Insemination market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Intravaginal Insemination market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Intratubal Insemination market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Assisted Reproductive Technology market: End-use outlook and key takeaways
Fig. 27 Assisted Reproductive Technology market: End-use movement analysis
Fig. 28 Fertility Clinics & Other Facilities market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Hospitals & Other Settings market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Company market share analysis, 2023
Fig. 31 Strategic framework